Monday, June 15, 2026

YG Plus Shares Drop 11% After Rosé’s “APT.” Success Boosted Stock

YG Plus stock dropped 11% on Tuesday, following a surge from Rosé's "APT." Poor earnings and profit-taking contributed to the decline.

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

Euro 2024 Shocker: Croatian and Polish Legends Falter

Luka Modric (Croatia) and Robert Lewandowski (Poland)...

Tag: Samjiyon

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.